As of 2025-10-30, the Relative Valuation of Cogent Biosciences Inc (COGT) is (43.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.00 USD, the upside of Cogent Biosciences Inc based on Relative Valuation is -374.2%.
The range of the Relative Valuation is (37.94) - (44.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 22.1x | 19.6x |
| Forward P/E multiples | 18.7x - 28.4x | 23.6x |
| Fair Price | (37.94) - (44.86) | (43.87) |
| Upside | -337.2% - -380.4% | -374.2% |
| Date | P/E |
| 2025-10-28 | -7.91 |
| 2025-10-27 | -7.97 |
| 2025-10-24 | -7.44 |
| 2025-10-23 | -7.30 |
| 2025-10-22 | -7.30 |
| 2025-10-21 | -7.80 |
| 2025-10-20 | -7.98 |
| 2025-10-17 | -8.06 |
| 2025-10-16 | -8.05 |
| 2025-10-15 | -8.15 |
| 2025-10-14 | -7.59 |
| 2025-10-13 | -7.97 |
| 2025-10-10 | -8.00 |
| 2025-10-09 | -7.96 |
| 2025-10-08 | -7.66 |
| 2025-10-07 | -7.59 |
| 2025-10-06 | -7.82 |
| 2025-10-03 | -7.75 |
| 2025-10-02 | -7.25 |
| 2025-10-01 | -6.95 |
| 2025-09-30 | -7.06 |
| 2025-09-29 | -6.95 |
| 2025-09-26 | -6.96 |
| 2025-09-25 | -6.54 |
| 2025-09-24 | -6.52 |
| 2025-09-23 | -6.36 |
| 2025-09-22 | -6.15 |
| 2025-09-19 | -5.89 |
| 2025-09-18 | -6.26 |
| 2025-09-17 | -6.08 |
| 2025-09-16 | -6.17 |
| 2025-09-15 | -6.10 |
| 2025-09-12 | -6.23 |
| 2025-09-11 | -6.30 |
| 2025-09-10 | -6.27 |
| 2025-09-09 | -6.30 |
| 2025-09-08 | -6.24 |
| 2025-09-05 | -6.42 |
| 2025-09-04 | -6.36 |
| 2025-09-03 | -6.43 |
| 2025-09-02 | -5.90 |
| 2025-08-29 | -5.94 |
| 2025-08-28 | -5.94 |
| 2025-08-27 | -6.08 |
| 2025-08-26 | -6.01 |
| 2025-08-25 | -5.80 |
| 2025-08-22 | -5.96 |
| 2025-08-21 | -5.79 |
| 2025-08-20 | -5.83 |
| 2025-08-19 | -5.78 |